BioMarin Pharmaceutical Inc. (BMRN)
Company Info
| ISIN | US09061G1013 |
|---|---|
| CUSIP | 09061G101 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $96.00 |
|---|---|
| Year Range | $71.48 - $96.00 |
| EMA (50) | $85.82 |
| EMA (200) | $82.50 |
| Average Volume | $1.21M |
| Market Capitalization | $17.75B |
BMRNShare Price Chart
Click Calculate to get results
BMRNPerformance
The chart shows the growth of $10,000 invested in BioMarin Pharmaceutical Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $50,660 for a total return of roughly 406.60%. All prices are adjusted for splits and dividends.
BMRNReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 7.84% | 7.97% |
| 6M | 8.46% | -6.88% |
| YTD | 8.66% | -11.66% |
| 1Y | 23.87% | -5.01% |
| 5Y | 3.22% | 11.56% |
| 10Y | 9.85% | 11.64% |
BMRNMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.32% | -11.86% | -1.31% | 5.51% | -7.65% | 10.30% | 3.84% | 11.56% | ||||
| 2021 | -5.60% | -6.46% | -2.48% | 3.19% | -0.80% | 7.94% | -8.04% | 9.75% | -8.22% | 2.51% | 8.91% | 2.39% |
| 2020 | -1.24% | 8.23% | -6.50% | 8.90% | 15.79% | 15.76% | -2.86% | -34.87% | -2.50% | -2.17% | 5.74% | 11.42% |
| 2019 | 15.29% | -5.00% | -4.75% | -3.71% | -3.85% | 4.15% | -7.39% | -5.37% | -10.21% | 8.62% | 10.24% | 4.76% |
| 2018 | 1.19% | -10.04% | -0.12% | 3.01% | 8.18% | 4.27% | 6.75% | -0.58% | -3.01% | -4.95% | 4.19% | -11.33% |
| 2017 | 5.78% | 7.19% | -6.55% | 9.18% | -8.56% | 3.63% | -3.40% | 2.80% | 3.19% | -11.80% | 4.52% | 3.93% |
| 2016 | -29.34% | 10.61% | 0.75% | 2.67% | 5.87% | -13.22% | 27.79% | -5.56% | -1.46% | -12.97% | 6.35% | -3.26% |
| 2015 | 7.48% | 10.20% | 16.39% | -10.09% | 12.07% | 8.93% | 6.94% | -11.64% | -18.51% | 11.13% | -18.52% | 9.85% |
| 2014 | -2.09% | 17.60% | -15.79% | -14.63% | -0.46% | 7.33% | -0.63% | 15.21% | 1.32% | 14.33% | 8.75% | 0.76% |
| 2013 | 11.57% | 5.61% | 7.40% | 5.36% | -4.42% | -11.10% | 15.98% | 1.27% | 10.23% | -12.88% | 12.01% | -0.11% |
| 2012 | 3.66% | 0.31% | -4.20% | 1.31% | 2.71% | 11.05% | -0.73% | -4.96% | 7.82% | -8.07% | 31.05% | 1.44% |
| 2011 | -5.61% | -3.78% | 2.74% | 7.00% | 4.98% | -3.61% | 14.77% | -5.27% | 7.72% | 7.03% | 1.50% | -0.69% |
| 2010 | 2.53% | 2.93% | 16.85% | -0.00% | -16.47% | -2.87% | 15.24% | -7.14% | 10.15% | 16.82% | 3.72% | -0.55% |
BMRNDividend History
BioMarin Pharmaceutical Inc. doesn't pay dividends
BMRNDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
BMRNWorst Drawdowns
The table below shows the maximum drawdowns of the BioMarin Pharmaceutical Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the BioMarin Pharmaceutical Inc. is 56.90%, recorded on Oct 2, 2019. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -56.9% | Jul 21, 2015 | 1058 | Oct 2, 2019 | — | — | — |
| -33.02% | Feb 28, 2014 | 97 | Jul 17, 2014 | 76 | Nov 3, 2014 | 173 |
| -26.18% | Apr 6, 2010 | 64 | Jul 6, 2010 | 82 | Oct 29, 2010 | 146 |
| -24.35% | Sep 20, 2013 | 35 | Nov 7, 2013 | 69 | Feb 20, 2014 | 104 |
| -23.09% | Aug 1, 2011 | 6 | Aug 8, 2011 | 29 | Sep 19, 2011 | 35 |
| -22.16% | May 15, 2013 | 28 | Jun 24, 2013 | 51 | Sep 5, 2013 | 79 |
| -17.07% | Feb 18, 2011 | 22 | Mar 22, 2011 | 50 | Jun 2, 2011 | 72 |
| -16.2% | Feb 8, 2012 | 43 | Apr 10, 2012 | 24 | May 14, 2012 | 67 |
| -15.06% | Jul 16, 2012 | 76 | Nov 1, 2012 | 2 | Nov 5, 2012 | 78 |
| -14.19% | Oct 31, 2011 | 14 | Nov 17, 2011 | 32 | Jan 5, 2012 | 46 |
BMRNVolatility Chart
Current BioMarin Pharmaceutical Inc. volatility is 31.81%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.